GENTAUR Belgium BVBA BE0473327336
Voortstraat 49, 1910 Kampenhout BELGIUM
Tel 0032 16 58 90 45
GENTAUR U.S.A Genprice Inc 6017 Snell Ave, Ste 357, SanJose, CA 95123
Tel (408) 780-0908, Fax (408) 780-0908, firstname.lastname@example.org
#4100-100-EB S. pombe UVDE Enzyme & Buffer
Product name : S. pombe UVDE Enzyme & Buffer
Catalog number : 4100-100-EB
Supplier name : Trevigen
Data sheet: Ask more or other datasheet now !
More Details about
Description: Exposure to UV irradiation can damage DNA through the formation of bipyrimidine DNA photoproducts that are potentially cytotoxic and mutagenic. The two major classes of dimeric photoproducts are cyclobutane pyrimidine dimers and (6-4)-photoproducts (see figure 1).
Ultraviolet Damage Endonuclease (UVDE) is a nuclease involved in the repair of bipyrimidine DNA photoproducts and acts as an alternative to base or nucleotide excision repair pathways.
Repair of pyrimidine dimers by UVDE-mediated excision occurs by cleavage immediately 5’ to the photoproduct site on the DNA strand in an ATPindependent manner, and is more efficient in vitro than
nucleotide excision repair.
Source: Trevigen’s UVDE is a fusion protein consisting of glutathione-S-transferase fused to a truncated form of the UVDE protein from Schizosaccharomyces pombe (GST-Δ228-UVDE). Unlike full length UVDE, which has proved to be unstable and difficult to solubilize, GST-Δ228-UVDE lacks 228 amino acids from the amino terminus (of UVDE) and is soluble and stable when stored at -80°C. The presence of the N-terminal deletion does not affect the native properties of the protein, and optimal activity occurs at 30°C.
Substrate Specificity: Enzymatic studies revealed that UVDE from Schizosaccharomyces pombe recognizes pyrimidine dimers, photoproducts, apurinic/apyrimidinic sites, uracil, dihydrouracil, and other non-UV-induced DNA adducts.1,2 Biochemical and genetic analysis also suggest that UVDE may be involved in orchestrating mismatch repair in vivo, and this enzyme is also active on insertion-deletion loops.
Storage Buffer: 50 mM Tris-Cl (pH 6.0), 10 mM glutathione, and 10% glycerol.
Storage Conditions: Store at -80 oC. For long term storage, freeze in working aliquots at -80 oC to avoid repeated freeze-thawing.
Assay Conditions & Analysis: UVDE treatment of supercoiled DNA, containing adducts such as cyclobutane pyrimidine dimers, leads to relaxation of the supercoiling resulting in a relative shift in electrophoretic mobility. This may be visualized in agarose gels by staining with an intercalating dye such as ethidium bromide. Qualitative evaluation is performed by comparing the relative amounts of DNA contained within bands corresponding to supercoiled DNA (ccc) and to nicked (relaxed) forms. There are other more sensitive dyes available (e.g. SYBR® Gold, (Molecular Probes)), which reduce the amount of DNA required per lane. The actual concentrations of DNA and enzyme, and incubation times may have to be adjusted for optimal results. For increased sensitivity, or if a specific gene or DNA strand is under investigation, the DNA may be transferred by Southern blot to a membrane and probed with
radiolabeled DNA fragments from the DNA strand or gene of interest.
Materials and Reagents:
30oC Incubator Test and Control DNA
Agarose Gel Electrophoresis Equipment and Pipettors and tips
Reagents Ice Bath
UV transilluminator 10 mg/ml EtBr in water
1. Prepare the test DNA at approximately 250 ng/μl in water. In assays utilizing other forms of DNA, e.g. mitochondrial DNA, the concentration of DNA may need to be increased. Avoid exposure of the DNA to UV and solar light during preparation and storage. Always run controls to check for damage that may be introduced during DNA preparation and handling.
2. For a 20 μl reaction mix combine the following on ice in microcentrifuge tubes:
3. Incubate all tubes at 30°C for 15 to 60 minutes.
4. Add 2 μl of 10X EDTA Loading Buffer (see appendix) to each tube.
5. Resolve DNA by agarose gel electrophoresis (e.g. use 1.0% Trevigel 5000 (cat#9806-050-P)).
6. Stain gel for 15 minutes in 0.5 μg/ml ethidium bromide in water.
7. Visualize by viewing under ultraviolet light.
Interpretation of results: By agarose gel electrophoresis, supercoiled plasmid DNA migrates faster than either nicked or linear DNA. The different migration patterns of the DNA forms and relative DNA content in each band allows for interpretation of conversion from supercoiled to nicked and/or linear DNA. Figure 2 illustrates relaxation of supercoiling by GST-Δ228-UVDE on plasmid DNA exposed to UV.
A 3.2 kb purified plasmid was treated with or without 1000 J/m2 UV at 254 nm. Approximately 1 μg of DNA was treated with or without 250 ng of GST-Δ228-UVDE for 45 minutes at 30°C and analyzed by electrophoresis on a 1 % Trevigel 5000 gel in 1X TAE buffer. The gel was stained with 0.5 μg/ml ethidium bromide for 15 minutes then photographed under ultraviolet light. GST-Δ228-UVDE does not exhibit activity on unmodified DNA (lane 2) and UV treatment alone does not alter the ratio of the DNA forms of the plasmid (lane 3). Treatment of UV irradiated DNA with GST-Δ228-UVDE converted the covalently closed circular plasmid to nicked and linear forms.
Note: When smaller quantities of DNA are treated with UVDE, some nicking activity may occur in control DNA reflecting UV damage in plasmid preparation.
1. 10X RECTM Buffer 5: 200 mM HEPES pH 6.5; 100 mM MgCl2; 10 mM MnCl2; 1M NaCl
2. 10X EDTA Loading Buffer: 25% Ficoll; 2% SDS; 10 mM EDTA pH 8.0
3. 0.5 μg/ml ethidium bromide: Prepare a 10 mg/ml stock solution of ethidium bromide in water. Store in a dark or foil covered bottle at room temperature.
Dilute 10 mg/ml stock solution 1 in 2000 in water, sufficient for gel immersion. The diluted stock may be reused several times if stored in the dark. Dispose of according to state and federal regulations.
Contact us about this product :
Our team will respond you as soon as possible !
52062 Aachen Deutschland
Support Karolina Elandt
Fax: (+49) 241 56 00 47 88
Logistic :0241 40 08 90 86
IBAN lautet DE8839050000107569353
Handelsregister Aachen HR B 16058
Umsatzsteuer-Identifikationsnummer *** DE 815175831
email@example.com | Gentaur
Genprice Inc, Logistics
547, Yurok Circle
San Jose, CA 95123
Tel (408) 780-0908,
Fax (408) 780-0908,
Genprice Inc, Invoices and accounting
6017 Snell Ave, Ste 357
San Jose, CA 95123
Canada Montreal +15149077481
Ceská republika Praha +420246019719
Finland Helsset +358942419041
Magyarország Budapest +3619980547
US New York+17185132983
WP142: mRNA processing
WP1493: Carbon assimilation C4 pathway
WP2340: Thiamine (vitamin B1) biosynthesis and salvage
WP2341: vitamin B1 (thiamin) biosynthesis and salvage pathway
WP2344: vitamin B6 (pyridoxine, pyridoxal, pyridoxamine) biosynthesis and salvage pathway
WP2349: vitamin B3 (niacin), NAD and NADP biosynthesis pathway
WP626: Abscisic Acid Biosynthesis
Related Genes :
[TP53 P53] Cellular tumor antigen p53 (Antigen NY-CO-13) (Phosphoprotein p53) (Tumor suppressor p53)
[APP A4 AD1] Amyloid beta A4 protein (ABPP) (APPI) (APP) (Alzheimer disease amyloid protein) (Amyloid precursor protein) (Beta-amyloid precursor protein) (Cerebral vascular amyloid peptide) (CVAP) (PreA4) (Protease nexin-II) (PN-II) [Cleaved into: N-APP; Soluble APP-alpha (S-APP-alpha); Soluble APP-beta (S-APP-beta); C99; Beta-amyloid protein 42 (Beta-APP42); Beta-amyloid protein 40 (Beta-APP40); C83; P3(42); P3(40); C80; Gamma-secretase C-terminal fragment 59 (Amyloid intracellular domain 59) (AICD-59) (AID(59)) (Gamma-CTF(59)); Gamma-secretase C-terminal fragment 57 (Amyloid intracellular domain 57) (AICD-57) (AID(57)) (Gamma-CTF(57)); Gamma-secretase C-terminal fragment 50 (Amyloid intracellular domain 50) (AICD-50) (AID(50)) (Gamma-CTF(50)); C31]
[KMT2A ALL1 CXXC7 HRX HTRX MLL MLL1 TRX1] Histone-lysine N-methyltransferase 2A (Lysine N-methyltransferase 2A) (EC 18.104.22.168) (ALL-1) (CXXC-type zinc finger protein 7) (Myeloid/lymphoid or mixed-lineage leukemia) (Myeloid/lymphoid or mixed-lineage leukemia protein 1) (Trithorax-like protein) (Zinc finger protein HRX) [Cleaved into: MLL cleavage product N320 (N-terminal cleavage product of 320 kDa) (p320); MLL cleavage product C180 (C-terminal cleavage product of 180 kDa) (p180)]
[APEX1 APE APE1 APEX APX HAP1 REF1] DNA-(apurinic or apyrimidinic site) lyase (EC 3.1.-.-) (EC 22.214.171.124) (APEX nuclease) (APEN) (Apurinic-apyrimidinic endonuclease 1) (AP endonuclease 1) (APE-1) (REF-1) (Redox factor-1) [Cleaved into: DNA-(apurinic or apyrimidinic site) lyase, mitochondrial]
[PSEN1 AD3 PS1 PSNL1] Presenilin-1 (PS-1) (EC 3.4.23.-) (Protein S182) [Cleaved into: Presenilin-1 NTF subunit; Presenilin-1 CTF subunit; Presenilin-1 CTF12 (PS1-CTF12)]
[SCN5A] Sodium channel protein type 5 subunit alpha (HH1) (Sodium channel protein cardiac muscle subunit alpha) (Sodium channel protein type V subunit alpha) (Voltage-gated sodium channel subunit alpha Nav1.5)
[S100A9 CAGB CFAG MRP14] Protein S100-A9 (Calgranulin-B) (Calprotectin L1H subunit) (Leukocyte L1 complex heavy chain) (Migration inhibitory factor-related protein 14) (MRP-14) (p14) (S100 calcium-binding protein A9)
[S 3] Spike glycoprotein (S glycoprotein) (E2) (Peplomer protein) [Cleaved into: Spike protein S1 (90B); Spike protein S2 (90A)]
[S100A8 CAGA CFAG MRP8] Protein S100-A8 (Calgranulin-A) (Calprotectin L1L subunit) (Cystic fibrosis antigen) (CFAG) (Leukocyte L1 complex light chain) (Migration inhibitory factor-related protein 8) (MRP-8) (p8) (S100 calcium-binding protein A8) (Urinary stone protein band A) [Cleaved into: Protein S100-A8, N-terminally processed]
[OR1F1 OLFMF OR1F10 OR1F4 OR1F5 OR1F6 OR1F7 OR1F8 OR1F9] Olfactory receptor 1F1 (Olfactory receptor 16-35) (OR16-35) (Olfactory receptor 1F10) (Olfactory receptor 1F4) (Olfactory receptor 1F5) (Olfactory receptor 1F6) (Olfactory receptor 1F7) (Olfactory receptor 1F8) (Olfactory receptor 1F9) (Olfactory receptor OR16-4)
[S 2] Spike glycoprotein (S glycoprotein) (E2) (Peplomer protein) [Cleaved into: Spike protein S1; Spike protein S2]
[TY1B-OR YORWTy1-2 POL YOR142W-B O3367 YOR3367W] Transposon Ty1-OR Gag-Pol polyprotein (Gag-Pol-p199) (TY1A-TY1B) (Transposon Ty1 TYA-TYB polyprotein) (p190) [Cleaved into: Capsid protein (CA) (Gag-p45) (p54); Ty1 protease (PR) (EC 3.4.23.-) (Pol-p20) (p23); Integrase (IN) (Pol-p71) (p84) (p90); Reverse transcriptase/ribonuclease H (RT) (RT-RH) (EC 126.96.36.199) (EC 188.8.131.52) (EC 184.108.40.206) (Pol-p63) (p60)]
[App] Amyloid beta A4 protein (ABPP) (APP) (Alzheimer disease amyloid A4 protein homolog) (Amyloid precursor protein) (Amyloidogenic glycoprotein) (AG) (Beta-amyloid precursor protein) [Cleaved into: N-APP; Soluble APP-alpha (S-APP-alpha); Soluble APP-beta (S-APP-beta); C99 (APP-C99); Beta-amyloid protein 42 (Beta-APP42); Beta-amyloid protein 40 (Beta-APP40); C83; P3(42); P3(40); C80; Gamma-secretase C-terminal fragment 59 (APP-C59) (Amyloid intracellular domain 59) (AID(59)) (Gamma-CTF(59)); Gamma-secretase C-terminal fragment 57 (APP-C57) (Amyloid intracellular domain 57) (AID(57)) (Gamma-CTF(57)); Gamma-secretase C-terminal fragment 50 (Amyloid intracellular domain 50) (AID(50)) (Gamma-CTF(50)); C31]
[S100B] Protein S100-B (S-100 protein beta chain) (S-100 protein subunit beta) (S100 calcium-binding protein B)
[RSP5 MDP1 NPI1 YER125W SYGP-ORF41] E3 ubiquitin-protein ligase RSP5 (EC 220.127.116.11) (HECT-type E3 ubiquitin transferase RSP5) (Reverses SPT-phenotype protein 5)
[TY2B-OR2 YORWTy2-2 POL YOR343W-B O6304] Transposon Ty2-OR2 Gag-Pol polyprotein (TY2A-TY2B) (Transposon Ty2 TYA-TYB polyprotein) [Cleaved into: Capsid protein (CA); Ty2 protease (PR) (EC 3.4.23.-); Integrase (IN); Reverse transcriptase/ribonuclease H (RT) (RT-RH) (EC 18.104.22.168) (EC 22.214.171.124) (EC 126.96.36.199)]
[N CG3936] Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein]
[OR1E1 OR1E5 OR1E6 OR1E9P] Olfactory receptor 1E1 (Olfactory receptor 13-66) (OR13-66) (Olfactory receptor 17-2/17-32) (OR17-2) (OR17-32) (Olfactory receptor 1E5) (Olfactory receptor 1E6) (Olfactory receptor 5-85) (OR5-85) (Olfactory receptor OR17-18) (Olfactory receptor-like protein HGMP07I)
[TY2B-OR1 YORCTy2-1 POL YOR192C-B O4785] Transposon Ty2-OR1 Gag-Pol polyprotein (TY2A-TY2B) (Transposon Ty2 TYA-TYB polyprotein) [Cleaved into: Capsid protein (CA); Ty2 protease (PR) (EC 3.4.23.-); Integrase (IN); Reverse transcriptase/ribonuclease H (RT) (RT-RH) (EC 188.8.131.52) (EC 184.108.40.206) (EC 220.127.116.11)]
[Oprm1 Ror-b] Mu-type opioid receptor (M-OR-1) (MOR-1) (Opioid receptor B)
[OPRM1 MOR1] Mu-type opioid receptor (M-OR-1) (MOR-1) (Mu opiate receptor) (Mu opioid receptor) (MOP) (hMOP)
[RPS3 OK/SW-cl.26] 40S ribosomal protein S3 (EC 18.104.22.168)
[S100A12] Protein S100-A12 (CGRP) (Calcium-binding protein in amniotic fluid 1) (CAAF1) (Calgranulin-C) (CAGC) (Extracellular newly identified RAGE-binding protein) (EN-RAGE) (Migration inhibitory factor-related protein 6) (MRP-6) (p6) (Neutrophil S100 protein) (S100 calcium-binding protein A12) [Cleaved into: Calcitermin]
[FBN1 FBN] Fibrillin-1 [Cleaved into: Asprosin]
[RPS27A UBA80 UBCEP1] Ubiquitin-40S ribosomal protein S27a (Ubiquitin carboxyl extension protein 80) [Cleaved into: Ubiquitin; 40S ribosomal protein S27a]
[Kmt2a All1 Hrx Mll Mll1] Histone-lysine N-methyltransferase 2A (Lysine N-methyltransferase 2A) (EC 22.214.171.124) (ALL-1) (Myeloid/lymphoid or mixed-lineage leukemia) (Myeloid/lymphoid or mixed-lineage leukemia protein 1) (Zinc finger protein HRX) [Cleaved into: MLL cleavage product N320 (N-terminal cleavage product of 320 kDa) (p320); MLL cleavage product C180 (C-terminal cleavage product of 180 kDa) (p180)]
[OR1D2 OLFR1] Olfactory receptor 1D2 (Olfactory receptor 17-4) (OR17-4) (Olfactory receptor OR17-6) (Olfactory receptor-like protein HGMP07E)
[OR2B6 OR2B1 OR2B1P OR2B5 OR2B6P] Olfactory receptor 2B6 (Hs6M1-32) (Olfactory receptor 2B1) (Olfactory receptor 2B5) (Olfactory receptor 5-40) (OR5-40) (Olfactory receptor 6-31) (OR6-31) (Olfactory receptor OR6-4)
[SCN1A NAC1 SCN1] Sodium channel protein type 1 subunit alpha (Sodium channel protein brain I subunit alpha) (Sodium channel protein type I subunit alpha) (Voltage-gated sodium channel subunit alpha Nav1.1)
[OR3A3 OR3A6 OR3A7 OR3A8P] Olfactory receptor 3A3 (Olfactory receptor 17-201) (OR17-201) (Olfactory receptor 3A6) (Olfactory receptor 3A7) (Olfactory receptor 3A8) (Olfactory receptor OR17-22)
 Evaluation of long-term neurodevelopment in twin-twin transfusion syndrome after laser therapy.
 Predicting stomatal responses to the environment from the optimization of photosynthetic gain and hydraulic cost.
 Uptake Pathways of Guandinylated Disulfide Containing Polymers as Nonviral Gene Carrier Delivering DNA to Cells.
 Epidemiology of Familial Aggregation of Venous Thromboembolism.
 Venous Thromboembolism in Patients Undergoing Craniotomy for Brain Tumors: A U.S. Nationwide Analysis.
 Main nutrient patterns and colorectal cancer risk in the European Prospective Investigation into Cancer and Nutrition study.
 Activity of c-Met/ALK Inhibitor Crizotinib and Multi-Kinase VEGF Inhibitor Pazopanib in Metastatic Gastrointestinal Neuroectodermal Tumor Harboring EWSR1-CREB1 Fusion.
 Determination of the Mutant Prevention Concentration and the Mutant Selection Window of Topical Antimicrobial Agents against Propionibacterium acnes.
 Strain survey and genetic analysis of vasoreactivity in mouse aorta.
 Risk stratifying emergency department patients with acute pulmonary embolism: Does the simplified Pulmonary Embolism Severity Index perform as well as the original?
Enter catalog number :